Daxor Corp
NASDAQ:DXR

Watchlist Manager
Daxor Corp Logo
Daxor Corp
NASDAQ:DXR
Watchlist
Price: 9.2842 USD 3.97% Market Closed
Market Cap: 44.9m USD
Have any thoughts about
Daxor Corp?
Write Note

Daxor Corp
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daxor Corp
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Daxor Corp
NASDAQ:DXR
Cash from Operating Activities
-$1.7m
CAGR 3-Years
12%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash from Operating Activities
$3.8B
CAGR 3-Years
-6%
CAGR 5-Years
3%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Cash from Operating Activities
$2.9B
CAGR 3-Years
12%
CAGR 5-Years
20%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Cash from Operating Activities
$3.8B
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Cash from Operating Activities
$7.9B
CAGR 3-Years
-11%
CAGR 5-Years
8%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Operating Activities
$1.8B
CAGR 3-Years
-5%
CAGR 5-Years
6%
CAGR 10-Years
10%
No Stocks Found

Daxor Corp
Glance View

Market Cap
44.9m USD
Industry
Health Care

Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. The company is headquartered in New York City, New York. The Company’s investment objectives are capital preservation, maintaining returns on capital with a high degree of safety and generating income from dividends and option sales to help offset operating losses from the Company’s operating division. The firm intends to maintain a diversified securities portfolio comprised primarily of electric utility company common and preferred stocks. The firm seeks to maintain a minimum of 80% of its portfolio in equity securities of utility companies.

DXR Intrinsic Value
3.2299 USD
Overvaluation 65%
Intrinsic Value
Price

See Also

What is Daxor Corp's Cash from Operating Activities?
Cash from Operating Activities
-1.7m USD

Based on the financial report for Jun 30, 2024, Daxor Corp's Cash from Operating Activities amounts to -1.7m USD.

What is Daxor Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-6%

Over the last year, the Cash from Operating Activities growth was 47%. The average annual Cash from Operating Activities growth rates for Daxor Corp have been 12% over the past three years , -6% over the past five years .

Back to Top